omega-n-methylarginine has been researched along with Diabetes Mellitus, Type 2 in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (23.08) | 18.2507 |
| 2000's | 24 (61.54) | 29.6817 |
| 2010's | 6 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arós, F; Bullo, M; Clish, C; Cofán, M; Corella, D; Dennis, C; Estruch, R; Fitó, M; Guasch-Ferré, M; Gutiérrez-Bedmar, M; Hu, FB; Lapetra, J; Liang, L; Martínez-González, MA; Papandreou, C; Razquin, C; Romaguera, D; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Serra-Majem, L; Sorlí, JV; Toledo, E; Wang, DD; Yu, E | 1 |
| Bech, JN; Hansen, AB; Jensen, JM; Larsen, T; Mose, FH; Pedersen, EB | 1 |
| Carallo, C; De Franceschi, MS; Gnasso, A; Grande, L; Irace, C; Mancuso, A; Muccari, D; Palange, AL; Scavelli, FB | 1 |
| Lai, J; Liu, H; Liu, X; Ming, J; Xing, Y; Zhang, N; Zhang, X | 1 |
| Nakano, T; Takahashi, Y; Wakabayashi, I | 1 |
| Delles, C; Ott, C; Ritt, M; Schmieder, RE; Schneider, MP | 1 |
| Cleland, SJ; Dawson, J; Harrow, C; Lees, KR; Quinn, T; Walters, MR; Weir, CJ | 1 |
| Brillante, DG; Brillante, RE; Howes, LG; O'Sullivan, AJ | 1 |
| Ott, C; Raff, U; Ritt, M; Schmieder, RE; Schneider, MP | 1 |
| Delles, C; Ott, C; Schlaich, MP; Schmieder, RE; Schneider, MP | 1 |
| Cerrato, R; Grönros, J; Jung, C; Lundberg, JO; Ostenson, CG; Pernow, J | 1 |
| Goto, D; Iida, M; Iwase, M; Tashiro, K; Uchizono, Y | 1 |
| Bradley, SJ; Formosa, M; Kingwell, BA; McConell, GK; Muhlmann, M | 1 |
| Bilsborough, W; Dembo, L; Green, D; O'Driscoll, G; Stanton, K; Taylor, R; Weerasooriya, R | 1 |
| Burke, V; Croft, KD; Playford, DA; Watts, GF | 1 |
| Domínguez, H; Hermann, T; Ihlemann, N; Køber, L; Rask-Madsen, C; Torp-Pedersen, C | 1 |
| Delles, C; Fleischmann, EF; Fleischmann, I; Oehmer, S; Schmieder, RE; Schneider, MP | 1 |
| Angelini, V; Cittadini, A; Cozzolino, D; Guardasole, V; Matarazzo, M; Napoli, R; Saccà, L; Torella, R; Zarra, E | 1 |
| Howes, JB; Howes, LG; Lowy, A; Tran, D | 1 |
| Iida, M; Iwase, M; Nakamura, U; Nohara, S; Sasaki, N; Sonoki, K; Uchizono, Y | 1 |
| Playford, DA; Watts, GF; Woodman, RJ | 1 |
| Green, DJ; Maiorana, AJ; O'Driscoll, G; Pyke, KE; Tschakovsky, ME; Weisbrod, CJ | 1 |
| Alem, M; Cleland, SJ; Connell, JM; Lees, KR; Nazir, FS; Small, M; Walters, MR | 1 |
| Alem, M; Cleland, S; Nazir, F; Small, M; Walters, M | 1 |
| Maxwell, SR; McKnight, JA; Waring, WS; Webb, DJ | 1 |
| Lee, JH; Ragolia, L; Xia, S | 1 |
| Bohlen, HG; Lash, JM | 1 |
| Andrews, JW; Brennan, GM; Hayes, JR; Henry, WR; Johnston, GD; McDermott, BJ; McGrath, LT; McVeigh, GE | 2 |
| Millar, JA; O'Brien, SF; Silvester, W; Watts, GF | 1 |
| Acampora, R; Coppola, L; D'Onofrio, F; Giugliano, D; Marfella, R; Nappo, F; Verrazzo, G; Ziccardi, P | 1 |
| Faletti, A; Gimeno, MA; Gonzalez, ET; Jawerbaum, A; Novaro, V | 1 |
| Gimeno, M; González, E; Jawerbaum, A; Novaro, V; Sinner, D | 1 |
| Colreavy, F; Green, D; Maiorana, A; O'Driscoll, G; Stanton, K; Taylor, R | 1 |
| Bergholm, R; Lahdenperä, S; Liu, ML; Mäkimattila, S; Mäntysaari, M; Schlenzka, A; Summanen, P; Syvänne, M; Taskinen, MR; Vakkilainen, J; Yki-Järvinen, H | 1 |
| Cleland, SJ; Connell, JM; Elliott, HL; Petrie, JR; Small, M | 1 |
| Baron, AD; Cronin, J; Crowde, K; Hempfling, A; Hook, G; Paradisi, G; Steinberg, HO | 1 |
| Albers, S; Heitzer, T; Krohn, K; Meinertz, T | 1 |
| Baggio, B; Bombonato, G; Bruseghin, M; Crepaldi, G; Dalla Vestra, M; Finucci, G; Fioretto, P; Nosadini, R; Sacerdoti, D; Saller, A; Sambataro, M; Sfriso, A; Velussi, M | 1 |
14 trial(s) available for omega-n-methylarginine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.
Topics: Aged; Arginine Vasopressin; Atorvastatin; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubules; Male; Middle Aged; Natriuretic Peptide, Brain; Nitric Oxide; omega-N-Methylarginine; Pulse Wave Analysis; Pyrroles; Renal Insufficiency, Chronic; Treatment Outcome; Vascular Stiffness; Vasopressins | 2014 |
Allopurinol and nitric oxide activity in the cerebral circulation of those with diabetes: a randomized trial.
Topics: Allopurinol; Carotid Arteries; Cerebrovascular Circulation; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Humans; Infusions, Intravenous; Male; Nitric Oxide; omega-N-Methylarginine; Placebos; Stroke | 2009 |
Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome.
Topics: Adult; Angiotensin II; Arteries; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular System; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Hemodynamics; Humans; Insulin Resistance; Male; Metabolic Syndrome; Nitric Oxide Synthase; omega-N-Methylarginine; Photoplethysmography; Receptor, Angiotensin, Type 1; Telmisartan; Vascular Resistance | 2009 |
Reduction in basal nitric oxide activity causes albuminuria.
Topics: Aged; Albumins; Albuminuria; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Regression Analysis | 2011 |
Nitric oxide synthase inhibition reduces glucose uptake during exercise in individuals with type 2 diabetes more than in control subjects.
Topics: Blood Glucose; Blood Pressure; Body Weight; Cholesterol; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Exercise; Femoral Artery; Glucose; Glycated Hemoglobin; Hemodynamics; Humans; Insulin; Lipoproteins; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen Consumption; Placebos; Reference Values; Regional Blood Flow; Triglycerides | 2002 |
Effect of lowering tumour necrosis factor-alpha on vascular endothelial function in Type II diabetes.
Topics: Acetylcholine; Analysis of Variance; Brachial Artery; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Nitric Oxide Synthase; Nitroglycerin; Nitroprusside; omega-N-Methylarginine; Pentoxifylline; Plethysmography; Regional Blood Flow; Tumor Necrosis Factor-alpha; Ultrasonography; Vasodilator Agents | 2002 |
Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes.
Topics: Acetylcholine; Antioxidants; Apolipoprotein A-I; Area Under Curve; Blood Circulation; Blood Pressure; Bradykinin; Cholesterol, HDL; Cholesterol, LDL; Coenzymes; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Enzyme Inhibitors; F2-Isoprostanes; Female; Fenofibrate; Forearm; Glycated Hemoglobin; Homocysteine; Humans; Hypolipidemic Agents; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Statistics as Topic; Systole; Treatment Outcome; Triglycerides; Ubiquinone; Vasodilator Agents | 2003 |
Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.
Topics: Acetylcholine; Aged; Analysis of Variance; Angiotensin II; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Forearm; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Infusions, Intravenous; Male; Middle Aged; Nitric Oxide Synthase; Nitroprusside; Norepinephrine; omega-N-Methylarginine; Pyridines; Vascular Resistance; Vasodilator Agents | 2005 |
Inhibition of nitric oxide increases arterial stiffness in Type 2 diabetic patients.
Topics: Arterial Occlusive Diseases; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Enzyme Inhibitors; Humans; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine | 2007 |
Lowering serum urate does not improve endothelial function in patients with type 2 diabetes.
Topics: Acetylcholine; Adult; Brachial Artery; Cross-Over Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Placebos; Urate Oxidase; Uric Acid | 2007 |
Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Topics: Acetylcholine; Arachidonic Acid; Arginine; Blood Glucose; Blood Platelets; Blood Pressure; Cell Membrane; Cholesterol; Diabetes Mellitus, Type 2; Dietary Fats; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Female; Fish Oils; Forearm; Glycated Hemoglobin; Heart Rate; Hemodynamics; Humans; Male; Membrane Lipids; Middle Aged; Nitric Oxide; Olive Oil; omega-N-Methylarginine; Plant Oils; Triglycerides; Vascular Resistance | 1993 |
Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus.
Topics: Acetylcholine; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Enalapril; Endothelium, Vascular; Forearm; Humans; Middle Aged; Nitroprusside; omega-N-Methylarginine | 1999 |
Insulin action is associated with endothelial function in hypertension and type 2 diabetes.
Topics: Age Factors; Aged; Body Mass Index; Cholesterol, HDL; Diabetes Mellitus, Type 2; Endothelium, Vascular; Enzyme Inhibitors; Glucose; Humans; Hyperinsulinism; Hypertension; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Middle Aged; Nitric Oxide; Norepinephrine; omega-N-Methylarginine; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2000 |
Nitric oxide modulation of renal and cardiac hemodynamics in type 2 diabetes.
Topics: Adult; Albuminuria; Cardiac Output; Coronary Circulation; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enzyme Inhibitors; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Reference Values; Renal Circulation | 2002 |
25 other study(ies) available for omega-n-methylarginine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Changes in arginine are inversely associated with type 2 diabetes: A case-cohort study in the PREDIMED trial.
Topics: Aged; Aged, 80 and over; Arginine; Case-Control Studies; Citrulline; Cohort Studies; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Diet, Mediterranean; Female; Humans; Incidence; Insulin Resistance; Male; Middle Aged; omega-N-Methylarginine; Ornithine; Risk Factors | 2019 |
Decreased platelet aggregation by shear stress-stimulated endothelial cells in vitro: description of a method and first results in diabetes.
Topics: Blood Platelet Disorders; Cells, Cultured; Diabetes Mellitus, Type 2; Down-Regulation; Endothelium, Vascular; Enzyme Inhibitors; Feasibility Studies; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Middle Aged; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Reproducibility of Results | 2015 |
Netrin-1 restores cell injury and impaired angiogenesis in vascular endothelial cells upon high glucose by PI3K/AKT-eNOS.
Topics: Adenoviridae; Case-Control Studies; Caspase 3; Cell Survival; Cells, Cultured; Chromones; Diabetes Mellitus, Type 2; Diabetic Foot; Female; Gene Expression Regulation; Genetic Vectors; Glucose; Human Umbilical Vein Endothelial Cells; Humans; L-Lactate Dehydrogenase; Male; Malondialdehyde; Middle Aged; Morpholines; Neovascularization, Physiologic; Netrin-1; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction | 2017 |
Increased induction of inducible nitric oxide synthase expression in aortae of type 2 diabetes rats.
Topics: Animals; Aorta; Diabetes Mellitus, Type 2; Enzyme Induction; Interleukin-1beta; Lipopolysaccharides; Male; Nitric Oxide; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Phenylephrine; Rats; Rats, Wistar; Vasoconstriction | 2008 |
Impact of the endothelial nitric oxide synthase gene G894T polymorphism on renal endothelial function in patients with type 2 diabetes.
Topics: Alleles; Analysis of Variance; Arginine; Ascorbic Acid; Body Mass Index; Cholesterol, HDL; Diabetes Mellitus, Type 2; Endothelium; Female; Genotype; Guanine; Hemodynamics; Homozygote; Humans; Kidney; Male; Middle Aged; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Polymorphism, Single Nucleotide; Renal Plasma Flow; Thymine; Triglycerides | 2008 |
Gender is related to alterations of renal endothelial function in type 2 diabetes.
Topics: Aged; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Endothelium, Vascular; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Renal Plasma Flow; Sex Characteristics | 2009 |
Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats.
Topics: Amino Acids; Animals; Arginase; Arginine; Blood Flow Velocity; Blood Glucose; Coronary Circulation; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Inhibitors; Insulin; Male; Microvessels; Nitrites; omega-N-Methylarginine; Rats; Rats, Wistar | 2011 |
Islet hyperperfusion during prediabetic phase in OLETF rats, a model of type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Diet, Reducing; Dietary Sucrose; Disease Models, Animal; Insulin; Islets of Langerhans; Male; omega-N-Methylarginine; Pancreas; Perfusion; Prediabetic State; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Regional Blood Flow; Species Specificity | 2002 |
Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans.
Topics: Acetylcholine; Adult; Arteriosclerosis; Blood Flow Velocity; Brachial Artery; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Endothelium, Vascular; Forearm; Glucose; Humans; Inflammation; Infusions, Intra-Arterial; Insulin; Insulin Antagonists; Insulin Resistance; Male; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Tumor Necrosis Factor-alpha; Vasodilation | 2003 |
Increased response of renal perfusion to the antioxidant vitamin C in type 2 diabetes.
Topics: Aged; Antioxidants; Arginine; Ascorbic Acid; Case-Control Studies; Diabetes Mellitus, Type 2; Drug Combinations; Enzyme Inhibitors; Female; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; omega-N-Methylarginine; Renal Circulation | 2004 |
Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients.
Topics: Acetylcholine; Aged; Blood Flow Velocity; Brachial Artery; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Glucose Clamp Technique; Humans; Infusions, Intra-Arterial; Insulin; Insulin Resistance; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Plethysmography; Vasodilation; Wine | 2005 |
Nateglinide, a non-sulfonylurea rapid insulin secretagogue, increases pancreatic islet blood flow in rats.
Topics: 3-O-Methylglucose; Administration, Oral; Anesthesia; Animals; Blood Glucose; Blood Pressure; Consciousness; Cyclohexanes; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Gastrointestinal Tract; Glucose; Hypoglycemic Agents; Injections, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Male; Nateglinide; Nitric Oxide Synthase; omega-N-Methylarginine; Phenylalanine; Rats; Rats, Inbred OLETF; Rats, Sprague-Dawley; Regional Blood Flow; Time Factors; Tolbutamide | 2005 |
Basal production of nitric oxide (NO) and non-NO vasodilators in the forearm microcirculation in Type 2 diabetes: associations with blood pressure and HDL cholesterol.
Topics: Acetylcholine; Aspirin; Blood Pressure; Case-Control Studies; Cholesterol, HDL; Diabetes Mellitus, Type 2; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Male; Middle Aged; Nitric Oxide; Nitroprusside; omega-N-Methylarginine; Plethysmography; Regional Blood Flow; Vasodilator Agents | 2006 |
Relationship between changes in brachial artery flow-mediated dilation and basal release of nitric oxide in subjects with Type 2 diabetes.
Topics: Brachial Artery; Cross-Over Studies; Diabetes Mellitus, Type 2; Endothelium, Vascular; Enzyme Inhibitors; Forearm; Humans; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Randomized Controlled Trials as Topic; Regional Blood Flow; Regression Analysis; Retrospective Studies; Vascular Resistance; Vasodilation | 2006 |
Blunted response to systemic nitric oxide synthase inhibition in the cerebral circulation of patients with Type 2 diabetes.
Topics: Adult; Area Under Curve; Carotid Arteries; Case-Control Studies; Diabetes Mellitus, Type 2; Endothelium, Vascular; Humans; Infusions, Intravenous; Male; Middle Aged; Nitric Oxide Synthase; omega-N-Methylarginine; Regional Blood Flow; Risk; Stroke; Ultrasonography, Doppler, Transcranial | 2006 |
Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats.
Topics: Aging; Angiotensin II; Animals; Antihypertensive Agents; Diabetes Mellitus, Type 2; Endothelium, Vascular; Imidazoles; Losartan; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Pyridines; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; rho-Associated Kinases; Signal Transduction; Up-Regulation; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2008 |
Endothelial-dependent vasodilation is preserved in non-insulin-dependent Zucker fatty diabetic rats.
Topics: Acetylcholine; Adenosine Diphosphate; Animals; Arginine; Arterioles; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; In Vitro Techniques; Intestines; Least-Squares Analysis; Male; Nitric Oxide; Nitroprusside; Obesity; omega-N-Methylarginine; Rats; Rats, Zucker; Thinness; Vasodilation | 1995 |
Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia.
Topics: Acetylcholine; Adult; Cholesterol, HDL; Diabetes Mellitus, Type 2; Endothelium, Vascular; Forearm; Humans; Hyperlipidemias; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Triglycerides; Vasodilation | 1996 |
L-arginine for testing endothelium-dependent vascular functions in health and disease.
Topics: Adenosine Diphosphate; Adult; Age Factors; Arginine; Blood Glucose; Blood Pressure; Blood Viscosity; Cholesterol; Diabetes Mellitus, Type 2; Diastole; Female; Humans; Hypercholesterolemia; Hypertension; Infusions, Intravenous; Male; Middle Aged; omega-N-Methylarginine; Platelet Aggregation; Reference Values; Regression Analysis; Smoking; Stereoisomerism; Systole | 1997 |
Nitric oxide mediates increased prostaglandin E production by oocyte-cumulus complexes in the non-insulin-dependent diabetic rat.
Topics: Animals; Chorionic Gonadotropin; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Oocytes; Prostaglandins E; Rats; Rats, Wistar | 1998 |
Nitric oxide modulates placental prostanoid production from late pregnant non-insulin-dependent diabetic rat.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Diabetes Mellitus, Type 2; Dinoprost; Dinoprostone; Enzyme Inhibitors; Female; Gestational Age; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Placenta; Pregnancy; Pregnancy in Diabetics; Prostaglandins; Rats; Rats, Wistar; Reference Values; Thromboxane B2 | 1998 |
Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.
Topics: Acetylcholine; Antioxidants; Apolipoproteins; beta Carotene; Blood Flow Velocity; Cardiovascular Diseases; Cholesterol; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Endothelium, Vascular; Humans; Lipoproteins; Lipoproteins, LDL; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Reference Values; Risk Factors; Vasodilation; Vitamin A; Vitamin E | 1999 |
Type II diabetes abrogates sex differences in endothelial function in premenopausal women.
Topics: Adult; Diabetes Mellitus; Diabetes Mellitus, Type 2; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Leg; Male; Methacholine Chloride; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Obesity; omega-N-Methylarginine; Premenopause; Risk Factors; Sex Characteristics; Vasodilator Agents | 2000 |
Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus.
Topics: Acetylcholine; Biopterins; Blood Flow Velocity; Diabetes Mellitus, Type 2; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Plethysmography; Vasodilation; Vasodilator Agents | 2000 |
Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus.
Topics: Acetylcholine; Analysis of Variance; Arginine; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Forearm; Humans; Ischemia; Male; Middle Aged; Muscles; Nitroglycerin; omega-N-Methylarginine; Reference Values; Regional Blood Flow; Vasodilation | 1992 |